Malignant neoplasm of unspecified fallopian tube
ICD-10 C57.00 is a billable code used to indicate a diagnosis of malignant neoplasm of unspecified fallopian tube.
Malignant neoplasm of the fallopian tube is a rare gynecologic cancer that arises from the epithelial cells lining the fallopian tubes. This neoplasm can be classified as primary or secondary, with primary tumors originating in the fallopian tubes and secondary tumors resulting from metastasis from other sites, such as the ovaries or uterus. Symptoms may include abdominal pain, abnormal vaginal bleeding, and pelvic mass. Diagnosis typically involves imaging studies, such as ultrasound or CT scans, and histopathological examination following surgical intervention. The staging of fallopian tube cancer is crucial for determining treatment options and prognosis, with staging typically following the FIGO (International Federation of Gynecology and Obstetrics) system. CA-125, a tumor marker, is often elevated in patients with fallopian tube malignancies and can be used to monitor treatment response and disease recurrence. Surgical approaches may include salpingo-oophorectomy, hysterectomy, and debulking procedures, often accompanied by chemotherapy depending on the stage of the disease.
Detailed pathology reports, imaging studies, surgical notes, and CA-125 levels.
Diagnosis and treatment planning for patients presenting with pelvic masses or abnormal bleeding.
Ensure accurate staging and differentiation from other gynecologic cancers.
Comprehensive imaging reports detailing findings related to the fallopian tubes.
Imaging for suspected malignancies or follow-up of known tumors.
Clear communication of imaging findings to assist in accurate coding.
Used for surgical intervention in cases of fallopian tube malignancy.
Operative report detailing the procedure and findings.
Ensure accurate coding based on surgical findings.
Common symptoms include abdominal pain, abnormal vaginal bleeding, and pelvic mass. Patients may also present with nonspecific gastrointestinal symptoms.